Amicus Therapeutics Inc (FOLD):企業の財務・戦略的SWOT分析

◆英語タイトル:Amicus Therapeutics Inc (FOLD) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH58553FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:52
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Amicus Therapeutics Inc (FOLD) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Amicus Therapeutics Inc (Amicus Therapeutics) is a biotechnology company that focuses on the research, development and commercialization of small molecules drugs and orally administered drugs known as pharmacological chaperones for the treatment of rare and orphan diseases. The company’s lead product, Migalastat HCl, a small molecule is indicated for the treatment of Fabry disease. The other development products in the pipeline include ATB200/AT2221 for the treatment of Pompe disease, Fabry disease, and other lysosomal storage disorders; Migalastat for other conditions; and enzyme replacement therapies for other rare diseases. It has presence in the US, the UK, Ireland, France, the Netherlands, Germany, Spain, Italy and Japan. Amicus Therapeutics is headquartered in Cranbury, New Jersey, the US.

Amicus Therapeutics Inc Key Recent Developments

Feb 18,2021: Amicus Therapeutics to Present at Upcoming Investor Conferences
Feb 17,2021: Amicus Therapeutics to Announce Full-Year 2020 Financial Results on March 1, 2021
Jan 21,2021: Amicus Therapeutics announces presentations and posters at the 17th Annual WORLDSymposium™ 2021
Jan 11,2021: Amicus Therapeutics reports preliminary 2020 revenue and provides 2021 outlook
Dec 07,2020: Amicus Therapeutics named a Great Place to Work-Certified Company in 2020

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Amicus Therapeutics Inc – Key Facts
Amicus Therapeutics Inc – Key Employees
Amicus Therapeutics Inc – Key Employee Biographies
Amicus Therapeutics Inc – Major Products and Services
Amicus Therapeutics Inc – History
Amicus Therapeutics Inc – Company Statement
Amicus Therapeutics Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Amicus Therapeutics Inc – Business Description
Geographical Segment: Ex-US
Performance
Geographical Segment: The US
Performance
R&D Overview
Amicus Therapeutics Inc – Corporate Strategy
Amicus Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Amicus Therapeutics Inc – Strengths
Amicus Therapeutics Inc – Weaknesses
Amicus Therapeutics Inc – Opportunities
Amicus Therapeutics Inc – Threats
Amicus Therapeutics Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Amicus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Amicus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Amicus Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 18, 2021: Amicus Therapeutics to Present at Upcoming Investor Conferences
Feb 17, 2021: Amicus Therapeutics to Announce Full-Year 2020 Financial Results on March 1, 2021
Jan 21, 2021: Amicus Therapeutics announces presentations and posters at the 17th Annual WORLDSymposium™ 2021
Jan 11, 2021: Amicus Therapeutics reports preliminary 2020 revenue and provides 2021 outlook
Dec 07, 2020: Amicus Therapeutics named a Great Place to Work-Certified Company in 2020
Aug 10, 2020: Amicus Therapeutics announces second quarter 2020 financial results and corporate updates
Jul 17, 2020: Amicus Therapeutics secures $400 million non-dilutive debt financing
May 07, 2020: Amicus Therapeutics announces first quarter 2020 financial results and corporate updates
Mar 23, 2020: Amicus Therapeutics confirms business continuity, 2020 strategic priorities and announces proactive efforts to support public health initiatives, patients & employees
Mar 20, 2020: Amicus opens gene therapy center focused on Rett Syndrome, Other Rare Diseases
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Amicus Therapeutics Inc, Key Facts
Amicus Therapeutics Inc, Key Employees
Amicus Therapeutics Inc, Key Employee Biographies
Amicus Therapeutics Inc, Major Products and Services
Amicus Therapeutics Inc, History
Amicus Therapeutics Inc, Other Locations
Amicus Therapeutics Inc, Subsidiaries
Amicus Therapeutics Inc, Key Competitors
Amicus Therapeutics Inc, Ratios based on current share price
Amicus Therapeutics Inc, Annual Ratios
Amicus Therapeutics Inc, Annual Ratios (Cont...1)
Amicus Therapeutics Inc, Interim Ratios
Amicus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Amicus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Amicus Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Amicus Therapeutics Inc (FOLD):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • HRG Group, Inc. (HRG)-石油・ガス分野:企業M&A・提携分析
    Summary HRG Group, Inc. (HRG), formerly, Harbinger Group Inc., is a diversified investment holding company, with interests in various businesses such as branded consumer products, which include consumer batteries, residential locksets, faucets, shaving and grooming products, personal care products, …
  • Legend Holdings Corporation (3396):企業の財務・戦略的SWOT分析
    Legend Holdings Corporation (3396) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Nabors Industries Ltd (NBR):石油・ガス:M&Aディール及び事業提携情報
    Summary Nabors Industries Ltd (Nabors) is an oil and gas contract services provider that offers offshore platform work over and drilling rigs. It also provides directional drilling services, performance tools and innovative drilling technologies and drilling instrumentation and software to the world …
  • Kylemore Services Group:企業の戦略・SWOT・財務分析
    Kylemore Services Group - Strategy, SWOT and Corporate Finance Report Summary Kylemore Services Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • ABB Ltd (ABBN)-エネルギー分野:企業M&A・提携分析
    Summary ABB Ltd. (ABB) is a provider of power and automation technologies. The company provides solutions for secure, energy-efficient generation, transmission and distribution of electricity and for increasing productivity in industrial, commercial and utility operations. ABB’s product and service …
  • Latin American Resources Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Latin American Resources Ltd (LAR) is an oil and gas company that offers exploration and development of natural resource properties for the production of oil and natural gas. The company's services include acquiring and developing oil and gas properties and its operational assets to achieve …
  • Hansen Medical Inc (HNSN)-医療機器分野:企業M&A・提携分析
    Summary Hansen Medical Inc (Hansen Medical), formerly Autocath Inc, a subsidiary of Auris Surgical Robotics Inc, is a medical device company that develops, manufactures and markets magellan robotic system for peripheral vascular intervention. The company’s products include robotic system, robotic ca …
  • Shengli Oil and Gas Pipe Holdings Ltd:企業の戦略・SWOT・財務情報
    Shengli Oil and Gas Pipe Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Shengli Oil and Gas Pipe Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Sumitomo Chemical Co., Ltd.:企業の戦略・SWOT・財務情報
    Sumitomo Chemical Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Chemical Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Bashneft (BANE):企業の財務・戦略的SWOT分析
    Bashneft (BANE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Tervita Corp:企業の戦略・SWOT・財務情報
    Tervita Corp - Strategy, SWOT and Corporate Finance Report Summary Tervita Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • BKW AG (BKW)-エネルギー分野:企業M&A・提携分析
    Summary BKW AG (BKW) is a provider of energy services. The company plans, builds and operates infrastructure to produce and supply energy. It generates electricity from varied fuel sources such as hydro, nuclear, fossil, and renewable sources primarily, wind and small hydro, besides solar and biomas …
  • Ra Medical Systems Inc (RMED):医療機器:M&Aディール及び事業提携情報
    Summary Ra Medical Systems Inc (Ra Medical Systems) is a medical device company that develops, designs, and commercializes excimer laser systems for the treatment of cardiovascular and dermatologic diseases. The company’s technology provides operational versatility and dose customization. Its produc …
  • Pierrel Spa (PRL)-製薬・医療分野:企業M&A・提携分析
    Summary Pierrel Spa (Pierrel) is a pharmaceutical company that offers contract services to biopharmaceutical and life sciences industries across the world. The company offers services in the areas of contract research, discovery of medicinal product candidates, clinical research and contract manufac …
  • CenterPoint Energy Inc (CNP)-石油・ガス分野:企業M&A・提携分析
    Summary CenterPoint Energy, Inc. (CenterPoint) is an energy utility company. The company through its subsidiaries offers electricity transmission and distribution, natural gas distribution, natural gas sales and services, pipelines services and other field services. It sells regulated intrastate nat …
  • Medigus Ltd (MDGS):企業の財務・戦略的SWOT分析
    Summary Medigus Ltd (Medigus) is a medical device company that develops, produces and markets endoscopic surgical devices for minimally invasive medical procedures. The company flagship product, Medigus ultrasonic surgical endostapler (MUSE) system, a comprehensive endoscopic device for the treatmen …
  • SL Green Realty Corp:企業のM&A・事業提携・投資動向
    SL Green Realty Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SL Green Realty Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Samyang Biopharmaceuticals Corp-製薬・医療分野:企業M&A・提携分析
    Summary Samyang Biopharmaceuticals Corp (Samyang Biopharm) researches and develops technology platforms for drug delivery. Its product portfolio comprises transdermal patches, injections, ORC hemostat and others. The company spans its expertise in the development and distribution of biodegradable, s …
  • AcelRx Pharmaceuticals Inc (ACRX):企業の財務・戦略的SWOT分析
    AcelRx Pharmaceuticals Inc (ACRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Tangent Energy Solutions, Inc.:企業の戦略的SWOT分析
    Tangent Energy Solutions, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆